Neuclone Makes Progress With Ustekinumab Trial

Australian Firm Hails Phase I Results For Stelara Rival

 
• By David Wallace
Phase_One
NeuClone has reported progress in its Phase I trial for ustekinumab • Source: Shutterstock

More from Biosimilars

More from Products